BSE filing, NSE: VISTAPH. Summary written from the filing by ALFA Finder's alert engine.
Vista Pharmaceuticals Ltd: key numbers
- Share price
- ₹6.14
- Market cap
- ₹37.79 Cr
- Revenue (annual)
- ₹5.40 Cr
- Net profit (annual)
- ₹-12.06 Cr
- P/E (TTM)
- -3.2×Sector 46.1×
- Promoter holding
- 21.19%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vista Pharmaceuticals Ltd
All →Vista Pharmaceuticals Q1 FY27 Results: Net Loss of ₹1 Cr, Loss Narrows
Vista Pharmaceuticals Ltd reported a net loss of ₹1 Cr for Q1 FY27.
- Key figure
- Net loss ₹1 Cr
Vista Pharmaceuticals Board Meeting Date
Vista Pharmaceuticals has scheduled a board meeting for August 14, 2026. The board will consider the unaudited financial results for the quarter ended June 30, 2026.
Vista Pharmaceuticals Other Announcement
Vista Pharmaceuticals Ltd submitted its quarterly shareholding pattern for the period ending June 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Vista Pharmaceuticals Other Announcement
Vista Pharmaceuticals Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory compliance with no material deviations.
Vista Pharmaceuticals Q4 FY26 Results: Net Loss of ₹5.9 Cr, Loss Widens
Vista Pharmaceuticals Ltd reported a net loss of ₹5.9 Cr for Q4 FY26.
- Key figure
- Net loss ₹5.9 Cr
Vista Pharmaceuticals Financial Results
Vista Pharmaceuticals reported audited financial results for the year ended March 31, 2026. The company also appointed M/s. LMN & Co. as internal auditors.
Other management change announcements
All →Hexaware Technologies Management Change
Hexaware appointed Arjun Shah and Gregory Zeluck as Non-Executive Directors from 28 October 2026. Directors Neeraj Bharadwaj and Julius Genachowski resigned, and Girish Pai's resignation is effective 13 November 2026.
GMR Airports Management Change
GMR Airports appointed Sanjeev Gupta as Executive Director (Deputy CEO) effective 29 October 2026. Non-Executive Director Alexis Riols resigned effective 28 October 2026.
Raymond Realty Management Change
Raymond Realty said joint statutory auditor Chaturvedi & Shah LLP resigned on 28 October 2026 after a dispute over audit fee revision. Walker Chandiok & Co LLP continues as the other statutory auditor.
Aarti Pharmalabs Management Change
Aarti Pharmalabs accepted CFO Piyush Lakhani's resignation, effective 30 October 2026, and appointed Vibha Thakker as CFO from 31 October 2026. The filing records a senior management change with no monetary amount.
TruCap Finance Management Change
TruCap Finance designated three employees as Senior Management Personnel, effective 29 October 2026. The changes are additional charges for Product, Operations and Contact Centre roles.
Sayaji Hotels (Indore) Management Change
Sayaji Hotels (Indore) appointed Azhar Yusuf Dhanani as Additional Non-Executive Non-Independent Director effective October 28, 2026. Shareholder approval is required within three months.